US 8916159
Selenocysteine mediated hybrid antibody molecules
granted A61KA61K47/68A61K47/6809
Quick answer
US patent 8916159 (Selenocysteine mediated hybrid antibody molecules) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K47/68, A61K47/6809, A61K47/6811, A61K47/6849